Newsroom

LONDON--(BUSINESS WIRE)--  Lanark Master Issuer Plc Issue of GBP 750,000,000.00 class 1A notes due December 2069 Series 2024 1 MTN RegS ISSUE NAME. Our Ref. MQ4324 ISIN Code. XS2739632946 INTEREST AMT PER DENOM. CURRENCY CODE. GBP DAY BASIS. ACTUAL/365 FIXED (A005) NUM OF DAYS. 88 INTEREST RATE. 4.24555 PCT VALUE DATE. 22/05/2026 INTEREST PERIOD. 23/02/2026 TO 22/05/2026 GBP 1,000.00 IS GBP 6.62 POOL FACTOR. 0.6466667...

LONDON--(BUSINESS WIRE)--  Commonwealth Bank of Australia Issue of GBP 200,000,000.00 Floating Rate Notes due August 2026 Series 6687 Tranche 1 MTN ISSUE NAME. Our Ref. MU1061 ISIN Code. XS3162353281 TOTAL INTEREST AMT. CURRENCY CODE. GBP DAY BASIS. ACTUAL/365 FIXED (A005) NUM OF DAYS. 88 INTEREST RATE. 4.08555 PCT VALUE DATE. 22/05/2026 INTEREST PERIOD. 23/02/2026 TO 22/05/2026 GBP 1,970,018.63 POOL FACTOR. N/A...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris – FR001400AHX6), a company specialized in molecular diagnostics for infectious diseases, announces that its Board of Directors, at its meeting held on April 30, 2026, has decided to propose to the Combined General Meeting to be held on June 30, 2026 the distribution of a dividend of €0.11 per share for the financial year ended December 31, 2025. This proposal, which remains subject to shareholders’ approval, is in...

NEW YORK--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pzena Investment Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mus...

SANTA CLARA, Calif.--(BUSINESS WIRE)--VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), announced today the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer. Rowland previously served as Chief Executive Officer and President of Endotronix, where he led the development and commercialization of the Cordella™ Pulmonary Artery Sensor and Heart Failure System. Under his leadership, Endotronix raised over $150 millio...

LONDON--(BUSINESS WIRE)--  Please be advised that the following issue has redeemed early: ISIN: XS2348420303/ US27889PAB94 Issuer: Ecobank Transnational Incorporated Call Date: 17/06/2026 Amount Redeeming: USD 350,000,000 Call Price: 100%...

NEW YORK--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pzena Investment Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries mus...

PARIS & DALLAS--(BUSINESS WIRE)--Tulyp Medical, a Paris-based medical device company developing an intelligent pressure-driven perfusion system, today announced the appointment of Steve Motes as Chief Executive Officer. The appointment follows positive results from the company’s first-in-human study. Steve joins Tulyp with more than 30 years of experience in the medical device industry, primarily focused on cardiovascular technologies. He has held leadership roles at Draeger, Medtronic (formerl...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris – FR001400AHX6), société spécialisée dans le diagnostic moléculaire des maladies infectieuses, annonce que son Conseil d’administration du 30 avril 2026 a décidé de proposer à l’Assemblée générale mixte du 30 juin 2026 le versement d’un dividende de 0,11 € par action au titre de l’exercice clos le 31 décembre 2025. Cette proposition, qui sera soumise à l’approbation des actionnaires, s’inscrit dans la continuité d...

WORMERVEER, Netherlands--(BUSINESS WIRE)--Regulatory News: Pet Service Holding NV (Euronext Growth Paris, ISIN: NL0015001HZ9 / Ticker: ALPET), announces that revenue development during the first quarter of 2026 exceeded expectations. Revenue for the first quarter of 2026 amounted to approximately €3.8 million, compared to approximately €3.3 million in the same period of 2025, representing an increase of more than 15% year-on-year. Based on current developments, the Company expects that the prev...